Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Antibody 130

Antibody DNA Development Vaccination 130

Drug Discovery World

MAY 22, 2023

Large pharma involvement in advanced therapies has seen ebbs and flows, with AstraZeneca taking a larger stake in the market and Takeda developing its automation and digital capabilities, but also with GSK letting go of its CGT projects, along with most of the staff involved in its R&D. But are these price tags a barrier to access?

Gene Therapy 52

Gene Therapy Gene Drugs Contamination 52

XTalks

MARCH 22, 2023

In the span of two years, there was a flurry of these types of David-and-Goliath acquisitions, including Johnson & Johnson buying Actelion , Gilead Sciences gaining Kite Pharma and Takeda Pharmaceutical acquiring Shire. In 2019, BMS acquired Celgene in a $74 billion deal.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97